Mesoblast
Mesoblast is an Australia-based regenerative medicine company that develops allogeneic cellular medicines for the treatment of inflammatory and cardiovascular diseases.
Business Model:
Revenue: $8.1M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Mesoblast Information
Geographic Data
Address: 55 Collins Street
City: Melbourne
State: victoria
Zip: 3000
Country: AU
Financial Info
Stage:
post ipo equity
Raised Last:
$110M
Raised Total:$412M
Social
Metrics
2,663,817Website Global Rank
5,073Website Monthly Traffic
Twitter Followers
Description
Mesoblast is an Australia-based regenerative medicine company that develops allogeneic cellular medicines for the treatment of inflammatory and cardiovascular diseases.
Contact Phone:
Contact Email:
Mesoblast went public on 3/14/2013 on the Australian Securities Exchange
Listed Exchange:
Australian Securities Exchange
IPO Date:
3/14/2013
Ticker Symbol:
MSB
Amount Raised:
$170M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2014 | Osiris Therapeutics | Post-IPO Equity | 0 |
| 4/2014 | Osiris Therapeutics | Post-IPO Equity | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Private Placement | $45M |
M&G Investments UK |
3/2021 | Post-IPO Equity | $110M | 3/2018 | Debt | $75M |
Hercules Capital, Inc. |
5/2020 | Post-IPO Equity | $90M | 7/2018 | Post-IPO Equity | 1 | $50M |
Novaquest Capital Management Novaquest Capital Management Novaquest Capital Management Novaquest Capital Management |
1/2019 | Post-IPO Debt | 1 | $75M |
Hercules Capital Hercules Capital Hercules Capital Hercules Capital |
10/2019 | Post-IPO Equity | $50.6M | 3/2017 | Post-IPO Equity | $30.5M | 5/2016 | Post-IPO Equity | 1 | $6.2M |
Australian Government for Research &a; Development Australian Government for Research &a; Development Australian Government for Research &a; Development Australian Government for Research &a; Development |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2010 | Angioblast Systems |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
